Laetitia leads our efforts on vaccines policy and advocacy to encourage pharmaceutical innovation and improve people’s health and well-being around the world.
She oversees the Vaccines Committee, the interface between IFPMA members and international public health organizations involved in global immunization, which promotes sustainable policies and initiatives to support vaccine innovation and access to vaccines globally.
Prior to joining IFPMA, Laetitia worked as a clinical research associate for the multidisciplinary center on oncology at the University Hospital Lausanne.
She has a PhD in Molecular Biology from the University of Lausanne, Switzerland.
The COVID-19 pandemic has shown that, when we work together, we can achieve more than we ever thought possible. Together, we can give vaccines the greatest chance to make an even greater impact on our health, our communities, and our world.
More from Laetitia
Longer healthier lives, stronger economies: The potential for Europe’s preventive care agenda to set a global example
In this op-ed, authors argue that Europe will be among the first to confront the central question of how to ensure that longer lives are spent in good health. By treating preventive care as the investment it is, Europe can turn longer lives into stronger economies and set an example for others facing the same shift.
Read more
Building pandemic readiness through routine vaccination
In her latest blog for the Media Planet Global Health Resilience campaign launching online and within the Guardian, IFPMA Director for Vaccines Policy, Laetitia Bigger discusses strong routine immunization programs as essential health-security infrastructure, helping countries prevent disease, build public trust, maintain strong health systems, and respond faster and more effectively to future health crises.
Read more
Global resilience and national security starts with preventing ill health
Prevention is a necessity government must invest in to secure a stable and prosperous future for everyone.
Read more